DIP
AZN icon

DT Investment Partners’s AstraZeneca AZN Stock Holding History

DT Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65
Closed -$9.97K – 547
2025
Q3 		$9.97K Sell
65
-65
-50% -$9.84K ﹤0.01% 404
2025
Q2 		$18.2K Hold
130
– – ﹤0.01% 337
2025
Q1 		$19.1K Hold
130
– – ﹤0.01% 329
2024
Q4 		$17K Hold
130
– – ﹤0.01% 344
2024
Q3 		$20.3K Buy
+130
New +$21K ﹤0.01% 355

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DT Investment Partners's AZN Position: Q4 2025 in Review

DT Investment Partners sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 65 shares — an estimated $9.97K sold.

DT Investment Partners first reported a position in AZN in Q3 2024 and held it in 5 quarters. The position peaked at $20.3K in Q3 2024. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • DT Investment Partners reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • DT Investment Partners sold 65 AstraZeneca shares in Q4 2025, an estimated $9.97K.
  • DT Investment Partners first reported a position in AstraZeneca in Q3 2024 and held it in 5 quarters.
  • DT Investment Partners's AstraZeneca position peaked at $20.3K in Q3 2024.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on DT Investment Partners's 13F filing for Q4 2025, filed 10 Feb 2026.